Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ONO-7018 |
| Synonyms | |
| Therapy Description |
ONO-7018 inhibits MALT1, which potentially leads to decreased growth of tumor cells expressing cleaved MALT1 substrates (Blood (2022) 140 (Supplement 1): 8874-8875). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ONO-7018 | ONO 7018|ONO7018|CTX 177|CTX-177|CTX 177 | MALT1 Inhibitor 6 | ONO-7018 inhibits MALT1, which potentially leads to decreased growth of tumor cells expressing cleaved MALT1 substrates (Blood (2022) 140 (Supplement 1): 8874-8875). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05515406 | Phase I | ONO-7018 | A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL | Active, not recruiting | USA | 0 |